The Stem Cell Unit primarily covers the generation of patient-specific iPSCs and CRISPR/Cas9-based genome editing of iPSCs. In the last years, we sucessfully completed nearly 200 reprogramming and more than 100 CRISPR/Cas9 genome editing projects.
The offer of the Stem Cell Unit currently comprises the following services:
- Generation, cultivation, characterization, genome editing and differentiation of patient-specific iPS cells Read more
- Responsibility and coordination of the biobank for patient-specific iPS cell lines and iPS derivatives Read more
- Consultation, provision of infrastructure, devices and protocols, support in the planning of projects, the design of experiments and the learning of the required range of methods as well as support in the application for grants and ethical evaluations Read more